RespiRx：新型尼古丁吸入器正在寻求FDA批准
RespiRx：新型尼古丁吸入器正在寻求FDA批准
RespiRx：新型尼古丁吸入器正在寻求FDA批准
2020年8月5日
Respira 科技计划在2021年下半年向食品和药物管理局（FDA）提交尼古丁雾化器，以批准其作为尼古丁替代疗法（NRT）。将尼古丁转化为气雾剂，《经济时报》上的一篇文章称该设备旨在扰乱了估计的6180亿美元的NRT市场， 当前，NRT市场被制药公司以及烟草公司最新的极具争议的卷烟替代品，即已有数十年历史的口香糖和贴剂所占据。” “现实是，我们有对尼古丁上瘾的人，他们以前从未尝试过可燃产品，”首席执行官Mario Danek在谈到电子产品时说。“他们习惯于藏匿产品，而我们拥有这种设计。”尽管RespiRx设备的外观类似于电子烟，但其工作原理更像是哮喘吸入器。通过吸入触发，RespiRx应该证明比传统的NRT（例如口香糖和贴片，如电子烟）更容易从吸烟过渡，它模仿了使用香烟的亲口体验。 该设备还具有蓝牙无线连接和自己的应用程序，因此也应该是技术友好型个人的最爱。就像正在生产的Juul装置一样，RespiRx的目标是通过提供通过手机应用程序计量并逐渐减少尼古丁摄入量的功能来使用户戒除尼古丁。 Voke去年4月在英国推出了类似的名为Voke的设备。该产品已经制造了多年，现在已被药品和医疗产品监管局（MHRA）许可作为药物和更安全的吸烟替代品。 像RespiRx一样，Voke可提供快速的尼古丁渴望释放，而没有热量，燃烧或蒸汽，并且以用户友好而闻名。但是，与前者不同，Voke看起来很像一包香烟，包括一个矩形盒子和一个插入其中的塑料香烟。价格也差不多，有20笔费用为£11.99。这也可能使该产品成为非常有效的NRT。 RespiRx: New Nicotine Inhaler Seeking FDA Approval August 5, 2020 Respira Technologies Inc. is planning to submit a nicotine nebulizer to the Food and Drug Administration (FDA) for authorization as nicotine replacement therapy (NRT) by late 2021. Converting nicotine to aerosol, an article on the Ecomomic Times said that the device aims to disrupt the estimated $618 billion NRT market which is “dominated by decades-old gums and patches from pharma companies as well as tobacco companies’ more recent, ..controversial cigarette alternatives.” “The reality is we have folks who are addicted to nicotine who never tried combustible products before,” said Chief Executive Officer Mario Danek, referring electronic products. “They’re used to sleeker products, and we have that design.”Although the RespiRx device is similar to an e-cigarette in appearance, it works more like an asthma inhaler. Triggered by inhalation, the RespiRx should prove an easier transition from smoking than traditional NRTs such as gums and patches, as like e-cigarettes, it emulates the hand-to-mouth experience of using a cigarette. The device should also be a favourite with tech-friendly individuals as it features blue-tooth wireless connectivity and its own app. Just like a Juul device that is in the works, the RespiRx aims to wean users off nicotine by providing the ability to meter and gradually reduce nicotine intake via the mobile phone app. VokeA similar device called Voke, was launched in the UK last April. This product had been in the making for years and has now been licensed as a medicine and a safer alternative to smoking by the Medicine and Healthcare products Regulatory Agency (MHRA). Like RespiRx, Voke delivers rapid nicotine craving relief without heat, combustion or vapour and is renowned for being user friendly. However unlike the former, Voke looks a lot like a packet of cigarettes, including a rectangular box, and a plastic cigarette which slots into it. The price is also similar, with 20 charges costing £11.99. This is also likely to make this product a very effective NRT.
微信公众号 
客户微信号
